(Q46105596)

19 December 2017

editorial

0 references

title

Warfarin and pharmacogenomic testing: what would Pascal do? (English)

1 reference

19 December 2017

1 reference

1 reference

J Russell Teagarden

1

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

19 December 2017

published in

Pharmacotherapy

1 reference

19 December 2017

volume

29

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

245-247

1 reference

19 December 2017

Warfarin: an old drug but still interesting

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Toward a general theory of indifference to research-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Warfarin pharmacogenetics: economic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

Time trends in warfarin-associated hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.3.245

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.3.245

1 reference

19 December 2017

1 reference

19 December 2017